Find Research Studies in Arizona for Influenza

Condition:   Influenza
Interventions:   Drug: Arbidol;   Drug: Placebos
Sponsors:   Capital Medical University;   University of Oxford;   Peking University;   National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention
Recruiting

Condition:   Influenza
Intervention:   Biological: Quadrivalent inactivated influenza vaccine (IIV)
Sponsors:   Stanford University;   National Institutes of Health (NIH);   National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting

Conditions:   Influenza;   Influenza-like Illness
Interventions:   Biological: Egg based influenza vaccines;   Biological: Recombinant influenza vaccines;   Biological: Cell-culture based influenza vaccines
Sponsors:   Henry M. Jackson Foundation for the Advancement of Military Medicine;   National Institute of Allergy and Infectious Diseases (NIAID);   Food and Drug Administration (FDA);   Defense Health Agency Immunization Healthcare Branch;   Armed Forces Health Surveillance Branch;   Naval Health Research Center;   United States Air Force School of Aerospace Medicine;   Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.;   Uniformed Services University of the Health Sciences
Recruiting

Condition:   Influenza
Intervention:   Biological: FluMist
Sponsors:   Stanford University;   National Institutes of Health (NIH);   National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting

Condition:   Severe Influenza
Interventions:   Drug: Oseltamivir Phosphate;   Drug: Xiyanping injection+Oseltamivir Phosphate
Sponsors:   Jiangxi Qingfeng Pharmaceutical Co. Ltd.;   The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine;   the first affiliated hospital of Liaoning university of traditional Chinese medicine;   Beijing Luhe Hospital;   Qingdao Municipal Hospital;   Cangzhou People's Hospital
Recruiting

Condition:   Influenza
Interventions:   Drug: Oseltamivir;   Biological: MEDI8852;   Drug: Placebo
Sponsor:   MedImmune LLC
Not yet recruiting

Condition:   Influenza
Intervention:   Biological: Seasonal influenza vaccine
Sponsor:   Emory University
Recruiting

Condition:   Influenza
Interventions:   Biological: aTIV Primer;   Biological: QIV Primer;   Biological: aTIV Booster;   Biological: QIV Booster
Sponsors:   Canadian Immunization Research Network;   Provincial Health Services Authority;   McGill University Health Centre/Research Institute of the McGill University Health Centre;   Université de Montréal;   Canadian Center for Vaccinology;   CHU de Quebec-Universite Laval;   Dalhousie University
Recruiting

Condition:   Influenza, Human
Intervention:   Biological: Treatment Group Live Attenuated Flu Vaccine (LAIV)
Sponsor:   University of Alabama at Birmingham
Not yet recruiting

Conditions:   Influenza;   Influenza Immunisation
Intervention:   Biological: Influenza Virus Quadrivalent Inactivated Vaccine
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting

Condition:   Influenza, Human
Interventions:   Biological: Fluzone 0.25 mL dose;   Biological: Fluzone 0.5 mL dose;   Other: natural influenza infection
Sponsors:   University of Rochester;   University of Chicago
Recruiting

Conditions:   Influenza;   Influenza Immunisation
Intervention:   Biological: Influenza Virus Quadrivalent Inactivated Vaccine
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting

Condition:   Influenza
Interventions:   Biological: Flucelvax;   Other: Human Challenge virus
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting

Condition:   Influenza
Intervention:   Biological: VRC-FLUNPF099-00-VP (H1ssF_3928)
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting

Condition:   Influenza
Intervention:   Biological: Quadrivalent inactivated influenza vaccine (IIV)
Sponsors:   Stanford University;   National Institutes of Health (NIH);   National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting

Condition:   Influenza
Interventions:   Biological: MVA-NP+M1;   Biological: Saline;   Biological: H3N2 (A/Belgium/2417/2015)
Sponsor:   Vaccitech Limited
Recruiting

Condition:   Influenza
Interventions:   Biological: Quadrivalent influenza vaccine;   Biological: Trivalent influenza vaccine A;   Biological: Trivalent influenza vaccine B
Sponsor:   Shanghai Institute Of Biological Products
Not yet recruiting

Conditions:   Influenza;   Influenza Immunisation
Intervention:   Biological: Influenza Virus Vaccine Inactivated
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting

Condition:   Influenza
Interventions:   Drug: Oseltamivir;   Drug: Paracetamol
Sponsor:   Rambam Health Care Campus
Not yet recruiting

Conditions:   Influenza;   Influenza Immunisation
Interventions:   Biological: Advax-CpG55.2;   Drug: AF03;   Biological: Influenza Virus Quadrivalent Inactivated Vaccine;   Biological: Quadrivalent Recombinant Seasonal Influenza Vaccine
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting

Condition:   Influenza
Interventions:   Drug: sirolimus and oseltamivir;   Drug: Oseltamivir
Sponsor:   Chinese University of Hong Kong
Not yet recruiting

Condition:   Influenza
Interventions:   Biological: QIV-IB;   Biological: TIVV-IB;   Biological: TIVY-IB;   Biological: QIV-IB Lot A;   Biological: QIV-IB Lot B;   Biological: QIV-IB Lot C
Sponsors:   Butantan Institute;   Fundação Butantan
Not yet recruiting

Condition:   Influenza
Interventions:   Drug: Baloxavir Marboxil;   Drug: Placebo
Sponsor:   Hoffmann-La Roche
Recruiting

Condition:   Influenza
Interventions:   Drug: N-acetyl cysteine;   Drug: 5% Dextrose
Sponsor:   Chinese University of Hong Kong
Not yet recruiting

Condition:   Influenza A
Interventions:   Drug: ZSP1273 200 mg;   Drug: Placebo;   Drug: ZSP1273-400 mg;   Drug: ZSP1273-600 mg
Sponsor:   Guangdong Raynovent Biotech Co., Ltd
Not yet recruiting

Condition:   Influenza
Interventions:   Biological: FluBlok;   Biological: Fluzone;   Biological: FluCelVax
Sponsors:   University of Rochester;   National Institutes of Health (NIH)
Recruiting

Condition:   Influenza
Intervention:  
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting

Condition:   Post Influenza
Intervention:  
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting

Condition:   Influenza
Intervention:   Drug: Baloxavir Marboxil
Sponsor:   Hoffmann-La Roche
Recruiting

Condition:   Influenza
Interventions:   Drug: Baicalein Tablets 400mg;   Drug: Baicalein Tablets 600mg;   Drug: blank control 0mg
Sponsor:   CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Not yet recruiting

Condition:   Influenza
Interventions:   Drug: Baloxavir Marboxil;   Other: Placebo
Sponsor:   Hoffmann-La Roche
Recruiting

Conditions:   Influenza;   Influenza Immunisation
Interventions:   Biological: Influenza Virus Monovalent A/H3N2/Bris 10 M2SR Live Vaccine;   Other: Placebo;   Biological: Quadrivalent MDCK Inactivated Influenza Vaccine
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting

Condition:   Influenza A
Interventions:   Biological: LD Sing2016 M2SR H3N2 influenza vaccine;   Biological: MD Sing2016 M2SR H3N2 influenza vaccine;   Biological: HD Sing2016 M2SR H3N2 influenza vaccine;   Biological: LD Bris10 M2SR H3N2 influenza vaccine;   Other: Placebo
Sponsor:   FluGen Inc
Recruiting

Condition:   Influenza
Intervention:   Biological: H5N1 pISV
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting

Conditions:   Influenza;   Influenza Immunisation
Intervention:   Biological: Influenza Virus Vaccine Inactivated
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting

Conditions:   Influenza Type A;   Influenza Type B
Interventions:   Device: ALiA Analyser;   Device: Influenza A+B Test Kit
Sponsors:   Sanwa BioTech Limited;   Prince of Wales Hospital, Shatin, Hong Kong;   Chinese University of Hong Kong
Not yet recruiting

Conditions:   Avian Influenza;   Influenza Immunisation
Interventions:   Biological: A/H7N9;   Drug: MF59 adjuvant;   Other: Phosphate Buffered Saline (PBS) diluent
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting

Condition:   Influenza
Interventions:   Drug: Peramivir;   Drug: Oseltamivir
Sponsor:   BioCryst Pharmaceuticals
Recruiting

Condition:   Influenza
Interventions:   Biological: M-001;   Biological: Saline
Sponsor:   BiondVax Pharmaceuticals ltd.
Recruiting

Condition:   Influenza A
Interventions:   Drug: Pimodivir 600 mg;   Drug: Placebo;   Other: SOC Treatment
Sponsor:   Janssen Research & Development, LLC
Recruiting

Condition:   Influenza A
Interventions:   Drug: Pimodivir 600 mg;   Drug: Placebo;   Other: SOC Treatment
Sponsor:   Janssen Research & Development, LLC
Recruiting

Condition:   Influenza -Like Illness
Interventions:   Drug: Norketotifen;   Drug: Placebo
Sponsor:   Emergo Therapeutics, Inc.
Not yet recruiting

Condition:   Influenza, Human
Intervention:   Other: Data collection
Sponsor:   GlaxoSmithKline
Recruiting

Conditions:   Influenza;   H7N9 Influenza
Interventions:   Biological: H7N9 antigen + adjuvant IB160;   Biological: H7N9 antigen + adjuvant SE;   Biological: H7N9 antigen without adjuvant;   Biological: Placebo (PBS)
Sponsor:   Butantan Institute
Recruiting

Condition:   Influenza, Human
Interventions:   Other: Blood sample;   Other: Nasal swab;   Other: Oropharyngeal swab;   Other: Stool sample;   Other: Symptom checklist
Sponsor:   St. Jude Children's Research Hospital
Recruiting

Condition:   Influenza
Intervention:  
Sponsor:   University of Pittsburgh
Recruiting

Condition:   Influenza (Healthy Volunteers)
Interventions:   Biological: Standard-Dose influenza virus surface antigens (haemagglutinin and neuraminidase), Inactivated, Influenza Vaccine Quadrivalent, 2019-2020 Northern Hemisphere Strains QIV-SD;   Biological: High-Dose Influenza Vaccine (split virion, inactivated), Quadrivalent (QIV-HD) 2019-2020 Northern Hemisphere formulation QIV-HD
Sponsor:   Sanofi Pasteur, a Sanofi Company
Not yet recruiting

Condition:   H7N9 Influenza
Interventions:   Biological: 15μg H7N9 Vaccine;   Biological: Aluminum Hydroxide Adjuvant
Sponsor:   Shanghai Institute Of Biological Products
Not yet recruiting

Condition:   Influenza, Human
Interventions:   Drug: Clarithromycin 250 MG;   Drug: Placebos
Sponsor:   The University of Hong Kong
Not yet recruiting

Condition:   Influenza, Human
Interventions:   Diagnostic Test: Procalcitonin;   Other: Pharmacist-Led Education
Sponsors:   University of California, Davis;   Roche Pharma AG
Recruiting

Condition:   Influenza A
Interventions:   Drug: VIR-2482;   Drug: Placebo
Sponsor:   Vir Biotechnology, Inc.
Not yet recruiting

Condition:   H7N9 Subtype of Influenza A Virus
Intervention:   Drug: Pimodivir
Sponsor:   Janssen Research & Development, LLC
Available

Condition:   Influenza, Human
Intervention:   Biological: Fluarix
Sponsor:   University of Rochester
Recruiting

Conditions:   Enterovirus Infections;   Influenza
Interventions:   Biological: EV71 vaccine and influenza vaccine;   Biological: EV71 vaccine;   Biological: influenza vaccine
Sponsors:   China National Biotec Group Company Limited;   Zhejiang Provincial Center for Disease Control and Prevention;   Henan Center for Disease Control and Prevention;   Guizhou Center for Disease Control and Prevention;   Wuhan Institute of Biological Products Co., Ltd;   Changchun Institute of Biological Products Co., Ltd.;   Peking University;   National Institutes for Food and Drug Control, China
Not yet recruiting

Conditions:   Influenza;   Organ Transplantation
Interventions:   Biological: High-dose influenza vaccine;   Biological: MF59-adjuvanted influenza vaccine;   Biological: Standard intramuscular influenza vaccine
Sponsors:   Oriol Manuel;   University Hospital, Basel, Switzerland;   University of Bern;   University Hospital, Geneva;   University of Zurich;   Cantonal Hospital of St. Gallen;   Fondazione Epatocentro Ticino
Recruiting

Conditions:   Heart Failure;   Influenza
Interventions:   Other: Sterile saline;   Drug: inactivated trivalent influenza vaccine
Sponsor:   McMaster University
Recruiting

Condition:   Influenza, Human
Interventions:   Biological: QIVc;   Biological: Comparator QIV
Sponsor:   Seqirus
Not yet recruiting

Condition:   Influenza, Human
Interventions:   Drug: KT07 Capsule;   Other: Placebo
Sponsor:   Yiling Pharmaceutical Inc.
Recruiting

Condition:   Influenza
Intervention:   Biological: Influenza A/Bethesda/MM2/H1N1 Challenge
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting

Condition:   Flu, Human
Intervention:   Behavioral: Brief educational intervention
Sponsor:   Agrupamento de Centros de Saúde de Dão Lafões
Not yet recruiting

Conditions:   Influenza;   Acute Respiratory Viral Infections
Interventions:   Drug: XC221;   Drug: Placebo
Sponsor:   PHARMENTERPRISES LLC
Recruiting

Conditions:   Influenza, Human;   Myocardial Injury
Intervention:  
Sponsor:   Örebro University, Sweden
Recruiting

Conditions:   Influenza, Human;   Immune Response
Interventions:   Biological: FluMist live attenuated influenza vaccine;   Biological: Flucelvax inactivated influenza vaccine
Sponsors:   Richard Zimmerman MD;   Centers for Disease Control and Prevention
Not yet recruiting

Condition:   Influenza
Interventions:   Biological: NBP607-QIV;   Biological: Agrippal
Sponsor:   SK Bioscience Co., Ltd.
Not yet recruiting

Conditions:   Influenza With Pneumonia;   Invasive Pulmonary Aspergillosis
Intervention:  
Sponsor:   Universitaire Ziekenhuizen Leuven
Recruiting

Conditions:   Influenza;   Acute Respiratory Infection;   Influenza-like Illness
Intervention:   Behavioral: Educational text messages
Sponsors:   Columbia University;   National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting

Condition:   Influenza, Human
Intervention:   Behavioral: Exercise
Sponsors:   University of Houston;   National Institute on Aging (NIA)
Recruiting

Conditions:   Asthma in Children;   Influenza Vaccine;   Immunization Coverage
Intervention:  
Sponsor:   Central Hospital, Nancy, France
Not yet recruiting

Conditions:   Influenza;   Respiratory Virus Syncitial;   Extra-respiratory
Intervention:   Other: observational
Sponsor:   Poitiers University Hospital
Recruiting

Condition:   Influenza Viral Infections
Intervention:   Diagnostic Test: Sofia Influenza A+B FIA
Sponsors:   University of Wisconsin, Madison;   Quidel Corporation
Recruiting

Conditions:   Influenza;   Immunization;   Older Adults;   Over Age 75
Intervention:   Biological: Influenza
Sponsor:   Johns Hopkins University
Recruiting

Condition:   Influenza
Interventions:   Biological: Live attenuated influenza vaccine (LAIV4);   Biological: Inactivated Influenza Vaccine (IIV4)
Sponsors:   Stanford University;   National Institutes of Health (NIH);   National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting

Conditions:   Influenza Vaccines;   Influenza, Human;   Cost of Illness;   Health Knowledge, Attitudes, Practice;   Immunization Programs
Intervention:   Other: No intervention
Sponsors:   Peking University;   Centers for Disease Control and Prevention, China;   Fudan University;   Shandong University
Recruiting

Condition:   Flu
Interventions:   Drug: Oseltamivir;   Drug: Diltiazem;   Drug: Placebos
Sponsors:   University Hospital, Lille;   Ministry of Health, France
Recruiting

Condition:   Flu
Interventions:   Drug: Fluad Vaccine;   Drug: Fluzone HD Vaccine
Sponsors:   David H. Canaday;   Case Western Reserve University;   US Department of Veterans Affairs;   Brown University;   National Institutes of Health (NIH);   National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting

Conditions:   Influenza, Human;   Pregnancy;   Birth Defect
Interventions:   Biological: Flucelvax Trivalent Influenza Vaccine;   Biological: Flucelvax Quadrivalent Influenza Vaccine
Sponsor:   Seqirus
Recruiting

Condition:   Immunity, Cellular
Intervention:   Drug: Influenza Vaccine
Sponsor:   Washington University School of Medicine
Recruiting

Condition:   Influenza, Human
Intervention:  
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting

Condition:   Aspergillosis; Pulmonary, Invasive (Etiology)
Interventions:   Drug: SOC +Posaconazole 18 MG/ML (milligram/milliliter);   Other: standard of care (SOC)
Sponsors:   Universitaire Ziekenhuizen Leuven;   Merck Sharp & Dohme Corp.
Recruiting

Conditions:   Myocardial Infarction;   Influenza, Human;   Influenza Vaccines;   Heart Failure;   Stroke
Interventions:   Biological: Influenza vaccine;   Biological: Placebo
Sponsors:   Ole Frobert, MD, PhD;   Swedish Heart Lung Foundation;   Sanofi Pasteur, a Sanofi Company;   Uppsala University;   Lytics
Recruiting

Conditions:   Influenza;   Novel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV);   Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
Intervention:  
Sponsors:   University of Minnesota - Clinical and Translational Science Institute;   National Institute of Allergy and Infectious Diseases (NIAID);   National Institutes of Health (NIH)
Recruiting

Condition:   Vaccine Adverse Reaction
Interventions:   Biological: Placebo;   Biological: H7N9 LAIV
Sponsors:   Research Institute of Influenza, Russia;   World Health Organization;   Institute of Experimental Medicine, Russia;   Joint Stock Company Microgen, Russia
Not yet recruiting

Conditions:   Influenza, Human;   Pregnancy;   Birth Defect
Intervention:   Biological: Afluria Influenza Vaccine
Sponsor:   Seqirus
Recruiting

Condition:   Acute Coronary Syndrome
Interventions:   Biological: Double Dose Quadrivalent Influenza Vaccine;   Biological: Standard Dose Quadrivalent Influenza Vaccine
Sponsors:   Hospital Israelita Albert Einstein;   Ministry of Health, Brazil
Recruiting

Condition:   Flu Vaccine
Intervention:  
Sponsor:   Vanderbilt University Medical Center
Not yet recruiting

Condition:   Influenza
Interventions:   Biological: Vaccine administration by a pharmacist;   Behavioral: Unmet vaccination needs identified and met;   Behavioral: Vaccination forecast review and patient education
Sponsor:   American Pharmacists Association Foundation
Recruiting

Conditions:   Asthma in Children;   Vaccine Adverse Reaction;   Vaccine Reaction;   Asthma;   Wheezing;   Influenza
Interventions:   Biological: Live Attenuated Influenza Vaccine (LAIV);   Biological: Inactivated Influenza Vaccine (IIV)
Sponsors:   Vanderbilt University Medical Center;   Centers for Disease Control and Prevention;   Duke University;   Children's Hospital Medical Center, Cincinnati
Recruiting

Condition:   Plasma Cell Neoplasm
Interventions:   Biological: Pneumococcal 13-valent Conjugate Vaccine;   Biological: Trivalent Influenza Vaccine
Sponsors:   Emory University;   Sanofi
Not yet recruiting

Conditions:   Depression;   Healthy
Intervention:   Biological: Influenza Vaccine
Sponsor:   University of Texas at Austin
Recruiting

Conditions:   Influenza;   Pneumonia;   Lower Respiratory Tract Infection;   Acute Myocardial Infarction;   Congestive Heart Failure;   Stroke
Interventions:   Biological: Flublok Quadrivalent;   Biological: Standard Dose Inactivated Influenza Vaccine (SD-IIV)
Sponsors:   Kaiser Permanente;   Sanofi Pasteur, a Sanofi Company
Recruiting

Condition:   Healthy Volunteer
Interventions:   Biological: Flucelvax;   Biological: Fluvirin;   Biological: Fluzone High Dose
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting

Conditions:   Chronic Lymphocytic Leukemia;   Diffuse Large B-Cell Lymphoma;   Follicular Lymphoma;   Mantle Cell Lymphoma;   Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
Intervention:   Biological: Inactivated Influenza Vaccine
Sponsor:   Emory University
Recruiting

Conditions:   Vaccination;   Infection
Interventions:   Other: Standardised Digital Intervention;   Other: Individualised Digital Intervention
Sponsors:   University of Nottingham;   Public Health England
Not yet recruiting

Conditions:   Respiratory Pathogens;   Upper Respiratory Tract Illness;   Lower Respiratory Tract Illness;   Acute Respiratory Infection
Intervention:   Diagnostic Test: Results available to provider
Sponsors:   University of Colorado, Denver;   Biofire
Recruiting

Condition:   Clinical Decision Support
Interventions:   Other: Current Version of the Influenza Alert;   Other: Alternate Modifications of the Influenza Alert
Sponsor:   NYU Langone Health
Recruiting

Condition:   Abdominal Cancer
Interventions:   Drug: Cialis;   Biological: Influenza vaccine
Sponsor:   Ottawa Hospital Research Institute
Recruiting

Conditions:   Obstructive Sleep Apnea;   Hypertension
Interventions:   Other: Hand grip isometric contraction;   Other: Control
Sponsor:   University of Pernambuco
Recruiting

Conditions:   Pain;   Muscle Strength;   Lateral Epicondylitis;   Kinesio Taping
Interventions:   Device: ESWT;   Other: Kinesiotaping Application
Sponsor:   Ankara Yildirim Beyazıt University
Not yet recruiting

Conditions:   Basilar Thumb Arthritis;   Wrist Fracture;   Measure Pressure Distribution and Resultant Forces Needed
Intervention:  
Sponsor:   Shaare Zedek Medical Center
Not yet recruiting

Conditions:   Hepatitis B;   Diphtheria;   Haemophilus Influenzae Type B Infection;   Tetanus;   Pertussis
Intervention:   Biological: Eupenta Inj.
Sponsor:   LG Chem
Not yet recruiting

Condition:   Rehabilitation, Tenodesis, Stroke
Intervention:   Other: Motor task specific training
Sponsor:   National Cheng-Kung University Hospital
Recruiting

Conditions:   Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Poliomyelitis;   Haemophilus Influenzae Type b Infection
Interventions:   Biological: DTwP-HepB-Sabin IPV-Hib;   Biological: Pentavalent vaccine and Salk IPV
Sponsor:   LG Chem
Not yet recruiting

Condition:   Stress
Interventions:   Behavioral: R-CBSM;   Biological: Influenza vaccine
Sponsors:   University of Miami;   Florida Department of Health
Recruiting

Condition:   Chronic Obstructive Pulmonary Disease (COPD)
Interventions:   Drug: Interferon Beta-1A;   Other: Placebo
Sponsor:   Synairgen Research Ltd.
Recruiting

Conditions:   Safety;   Adverse Event Following Immunisation;   Birth Outcomes
Interventions:   Biological: Quadrivalent Recombinant Influenza Vaccine;   Biological: Quadrivalent Inactivated Influenza Vaccine
Sponsors:   Duke University;   Children's Hospital Medical Center, Cincinnati;   Boston Medical Center;   Centers for Disease Control and Prevention
Recruiting

Conditions:   Virus Diseases;   RNA Virus Infections;   Respiratory Tract Diseases;   Respiratory Tract Infections
Interventions:   Biological: Quadrivalent VLP Vaccine;   Biological: Quadrivalent Comparator Vaccine
Sponsor:   Medicago
Recruiting

Conditions:   Bone Mineral Density;   Grip Strength;   Physical Performance
Intervention:   Diagnostic Test: Bone densitometry measurement
Sponsor:   Centre Hospitalier Régional d'Orléans
Not yet recruiting

Conditions:   Acute Myeloid Leukemia;   Allogeneic Hematopoietic Stem Cell Transplantation;   Conditioning;   Elderly
Interventions:   Drug: Decitabine;   Drug: Busulfan (BU);   Drug: Fludarabine(Flu)
Sponsors:   Nanfang Hospital of Southern Medical University;   Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University;   Guangzhou First People's Hospital;   Peking University People's Hospital;   Third Affiliated Hospital, Sun Yat-Sen University;   Zhujiang Hospital
Recruiting

Conditions:   Refractory Hematologic Cancer;   Allogeneic Stem Cell Transplantation
Intervention:   Drug: CLAME-FluBu
Sponsor:   Shanghai Jiao Tong University School of Medicine
Recruiting

Conditions:   Acute Myeloid Leukemia in Remission;   Myelodysplastic Syndromes;   Chronic Myeloid Leukemia in Remission;   Myeloproliferative Syndrome;   Myeloproliferative Disorder;   Acute Lymphoid Leukemia in Remission;   Multiple Myeloma;   Chronic Lymphoid Leukemia;   Non Hodgkin Lymphoma;   Hodgkin Lymphoma
Interventions:   Drug: Thymoglobulin;   Drug: Melphalan;   Drug: Fludarabine
Sponsors:   University of Liege;   Belgian Hematological Society Transplant Committee
Recruiting

Condition:   Multiple Sclerosis
Interventions:   Drug: Plegridy;   Drug: Prednisone;   Drug: Tylenol Pill
Sponsors:   Holy Name Medical Center, Inc.;   Biogen
Recruiting

Condition:   Multiple Sclerosis, Relapsing-Remitting
Interventions:   Drug: SC Peginterferon beta-1a;   Drug: SC interferon beta-1a;   Drug: SC interferon beta-1b
Sponsors:   Biogen;   AMS Advanced Medical Services GmbH
Recruiting

Conditions:   Sore Throat;   Dysuria;   Cough;   Common Cold;   Influenza
Interventions:   Other: Physical Consultation;   Other: Online Consultation
Sponsors:   Region Skane;   Doctrin;   Capio Group;   Capio Go;   Lund University
Recruiting

Conditions:   Cold;   Cold Symptom;   Flu;   Flu Symptom;   Supplement;   Stress;   Gastrointestinal Tolerance
Interventions:   Dietary Supplement: Beta-Glucan;   Dietary Supplement: Placebo
Sponsors:   Kemin Foods LC;   KGK Science Inc.
Recruiting

Conditions:   Complement Deficiency;   Antibody Deficiency;   Chronic Sinus Infection;   Meningitis, Bacterial;   Pneumonia, Bacterial;   Otitis Media;   Streptococcal Infection;   Neisseria Infections;   Haemophilus Influenza;   Pneumococcal Infections
Intervention:   Biological: Immunological diagnosis tests
Sponsors:   University Hospital, Lille;   Imagine Institute;   Octapharma;   CSL Behring;   Laboratoire français de Fractionnement et de Biotechnologies;   Air Liquide SA;   The Binding Site Ltd
Recruiting

Conditions:   Tuberculosis;   Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Haemophilus Influenzae Type b Infection;   Pneumonia, Bacterial;   Measles;   Rotavirus Infections;   Polio;   Yellow Fever
Intervention:   Behavioral: All Babies are Equal Initiative (conditional cash transfer program)
Sponsors:   GiveWell;   New Incentives;   All Babies are Equal Initiative
Recruiting

Condition:   Healthy Volunteers
Interventions:   Biological: GamFluVac;   Other: Placebo
Sponsor:   Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Not yet recruiting

Condition:   Chronic Obstructive Pulmonary Disease (COPD)
Interventions:   Dietary Supplement: oral probiotics;   Drug: aerosol inhaled amikacin;   Biological: combined vaccination
Sponsors:   Shanghai Zhongshan Hospital;   The First Affiliated Hospital of Guangzhou Medical University;   Ruijin Hospital
Not yet recruiting

Conditions:   Adenovirus;   Anesthesia;   Anxiety;   Anxiolysis;   Autism;   Autistic Disorder;   Bacterial Meningitis;   Bacterial Septicemia;   Benzodiazepine;   Bipolar Disorder;   Bone and Joint Infections;   Central Nervous System Infections;   Convulsions;   Cytomegalovirus Retinitis;   Early-onset Schizophrenia Spectrum Disorders;   Epilepsy;   General Anesthesia;   Gynecologic Infections;   Herpes Simplex Virus;   Infantile Hemangioma;   Infection;   Inflammation;   Inflammatory Conditions;   Intra-abdominal Infections;   Lower Respiratory Tract Infections;   Migraines;   Pain;   Pneumonia;   Schizophrenia;   Sedation;   Seizures;   Skeletal Muscle Spasms;   Skin and Skin-structure Infections;   Treatment-resistant Schizophrenia;   Urinary Tract Infections;   Withdrawal;   Sepsis;   Gram-negative Infection;   Bradycardia;   Cardiac Arrest;   Cardiac Arrhythmia;   Staphylococcal Infections;   Nosocomial Pneumonia;   Neuromuscular Blockade;   Methicillin Resistant Staphylococcus Aureus;   Endocarditis;   Neutropenia;   Headache;   Fibrinolytic Bleeding;   Pulmonary Arterial Hypertension;   CMV Retinitis;   Hypertension;   Chronic Kidney Diseases;   Hyperaldosteronism;   Hypokalemia;   Heart Failure;   Hemophilia;   Heavy Menstrual Bleeding;   Insomnia
Intervention:   Drug: The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:
Sponsors:   Daniel Benjamin;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   The Emmes Company, LLC
Recruiting

Condition:   Respiratory Disorders
Interventions:   Biological: GSK's investigational non-typeable Haemophilus influenzae (NTHi) and Moraxella catarrhalis (Mcat) multi-antigen vaccine (GSK3277511A) adjuvanted with AS01E;   Biological: Shingrix GSK's lyophilized formulation of the herpes zoster (HZ) vaccine (GSK1437173A)
Sponsor:   GlaxoSmithKline
Recruiting

Conditions:   Metabolic Myopathies;   Exercise Test;   Myalgia
Interventions:   Device: functional test;   Genetic: matching genotype with phenotype
Sponsor:   University Hospital, Brest
Recruiting

Condition:   Diffuse Intrinsic Pontine Glioma (DIPG)
Interventions:   Biological: TTRNA-DC vaccines with GM-CSF;   Biological: TTRNA-xALT;   Drug: Cyclophosphamide + Fludarabine Lymphodepletive Conditioning;   Drug: Dose-Intensified TMZ;   Drug: Td vaccine;   Biological: Autologous Hematopoietic Stem Cells (HSC)
Sponsors:   University of Florida;   Accelerate Brain Cancer Cure;   Lyla Nsouli Foundation
Recruiting